跳至主要内容
临床试验/CTRI/2020/11/029206
CTRI/2020/11/029206尚未招募未知

Pharmacogenomics and Population Pharmacokinetic Integration for Precision Therapy of Tapentadol in Palliative Cancer Patients

Manipal Academy of Higher Education0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients of age >18 years and <70 years, from either sex.
  • Patients with moderate to severe pain {pain >4 measured on numerical rating scale (NRS)}.
  • Willing to participate in the study and provide written informed consent.

排除标准

  • Pregnant/lactating women.
  • Patients already on MAO inhibitors, serotonin reuptake inhibitors, and Tricyclic antidepressants [contraindicated drugs].

研究者

相似试验

Treatment with Tapentadol in Cancer Patients | 临床试验